PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
PharmEnable has raised $7.5M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
PharmEnable's investors include Parkwalk Advisors, Martlet Capital, MP Healthcare Venture Management, Pitch@Palace, O2h Ventures.
PharmEnable is headquartered in Cambridge, United Kingdom.
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
PharmEnable is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PharmEnable — Funding & Investors." VCBacked, May 22, 2023, https://www.vcbacked.co/company/pharmenable. Accessed July 19, 2026.
VCBacked. (2023). PharmEnable — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/pharmenable
{{cite web |title=PharmEnable — Funding & Investors |url=https://www.vcbacked.co/company/pharmenable |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated